China H7N9 Bird Flu Vaccine Passes Animal Test As Cases Reach 120
This article was originally published in PharmAsia News
China researchers reported success so far in trials of a genetically engineered vaccine against the H7N9 avian influenza virus plaguing the country just as the case count reached 120, more than 25 of them fatal.
You may also be interested in...
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.